Ian F. Smith A.C.A., ACA, C.P.A., CPA Net Worth

The estimated Net Worth of Ian F Smith is at least $133 Million dollars as of 3 July 2024. Mr Smith owns over 3,255 units of Solid Biosciences Inc stock worth over $797,400 and over the last 21 years he sold SLDB stock worth over $132,583,803. In addition, he makes $44,110 as Exec. Chair at Solid Biosciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr CPA SLDB stock SEC Form 4 insiders trading

Mr has made over 72 trades of the Solid Biosciences Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 3,255 units of SLDB stock worth $24,380 on 3 July 2024.

The largest trade he's ever made was selling 745,685 units of Solid Biosciences Inc stock on 19 April 2013 worth over $60,967,206. On average, Mr trades about 12,968 units every 44 days since 2003. As of 3 July 2024 he still owns at least 106,462 units of Solid Biosciences Inc stock.

You can see the complete history of Mr Smith stock trades at the bottom of the page.

Mr. Ian F. Smith A.C.A., ACA, C.P.A., CPA biography

Ian F. Smith A.C.A., ACA, C.P.A., CPA is the Exec. Chair at Solid Biosciences Inc.

What is the salary of Mr CPA?

As the Exec. Chair of Solid Biosciences Inc, the total compensation of Mr CPA at Solid Biosciences Inc is $44,110. There are 14 executives at Solid Biosciences Inc getting paid more, with Carl Morris having the highest compensation of $4,052,210.

How old is Mr CPA?

Mr CPA is 55, he's been the Exec. Chair of Solid Biosciences Inc since . There are 2 older and 19 younger executives at Solid Biosciences Inc. The oldest executive at Solid Biosciences Inc is Stephen J. DiPalma M.B.A., 62, who is the Treasurer & Principal Accounting Officer.

What's Mr CPA's mailing address?

Ian's mailing address filed with the SEC is C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN, MA, 02129.

Insiders trading at Solid Biosciences Inc

Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ..., and Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.

What does Solid Biosciences Inc do?

solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.

Complete history of Mr Smith stock trades at Acorda Therapeutics Inc, Infinity Pharmaceuticals, Vertex Pharmaceuticals, Solid Biosciences Inc, Stoke Therapeutics, and Foghorn Therapeutics

Solid Biosciences Inc executives and stock owners

Solid Biosciences Inc executives and other stock owners filed with the SEC include:

• Carl Morris,
  Chief Scientific Officer
• Ilan Ganot,
  President, Chief Executive Officer, Co-Founder, Director
• Jennifer Ziolkowski,
  Chief Financial Officer, Treasurer
• Ilan Ganot,
  Co-founder, Pres, CEO & Director
• Dr. Carl Ashley Morris,
  Chief Scientific Officer
• Adam Koppel,
  Independent Director
• Lynne Sullivan,
  Independent Director
• Martin Freed,
  Independent Director
• Dr. Andrey Juan Zarur Ph.D.,
  Co-Founder
• Adam Stone,
  Independent Director
• Sukumar Nagendran,
  Independent Director
• Matthew Arnold,
  Independent Director
• Rajeev Shah,
  Independent Director
• Robert Huffines,
  Independent Director
• Ian F. Smith A.C.A., ACA, C.P.A., CPA,
  Exec. Chair
• Matthew Bennett Arnold,
  Co-Founder & Board Member
• Carlo Tanzi,
  IR Contact Officer
• Lynette Herscha,
  Chief Legal Officer and Secretary
• Joel Schneider,
  Chief Technology Officer and Head of Exploratory Research and Development
• Ian Smith,
  Chairman of the Board
• Gilad David Hayeem,
  Co-Founder
• Dr. Cathryn M. Clary M.B.A., M.D.,
  Acting Chief Medical Officer
• Erin Powers Brennan,
  Chief Legal Officer & Sec.
• Caitlin Lowie,
  VP of Communications & IR
• Stephen J. DiPalma M.B.A.,
  Treasurer & Principal Accounting Officer
• Dr. Joel Solomon Zev Schneider Ph.D.,
  Chief Operating Officer
• Michael Inbar CPA, M.B.A.,
  Sr. VP of Fin.
• Annie Ganot,
  Co-Founder & Director of Patient Advocacy
• Pedro Alvaro Amorrortu,
  Chief Operating Officer
• Jorge Armando Quiroz,
  Chief Medical Officer
• Capital Management, L.P.Ra ...,
  
• Advisors Llcperceptive Life...,
  
• Chase & Cojpmc Strategic In...,
  
• Advisors Llcedelman Joseph ...,
  
• Gilad David Hayeem,
  10% owner
• Juan Andrey Zarur,
  Director
• Kevin Tan,
  CFO & Treasurer
• Capital, Llc Boxer,
  10% owner
• Capital Management, L.P.Ra ...,
  
• Capital Life Sciences Inves...,
  
• Advisors Llcperceptive Life...,
  
• Capital Management, L.P.Ra ...,
  
• Jessie Hanrahan,
  Chief Regulatory Officer
• Erin Powers Brennan,
  Chief Legal Officer, Secretary
• Clare Kahn,
  
• Advisors Llcperceptive Life...,
  
• David T Howton,
  Chief Operating Officer
• Jennifer Marlowe,
  CSO
• Alexander Cumbo,
  President and CEO
• Paul Herzich,
  Chief Technology Officer
• Gabriel Brooks,
  Chief Medical Officer
• Georgia Keresty,